Status:
ACTIVE_NOT_RECRUITING
Energy Balance and Breast Cancer Aspects-II
Lead Sponsor:
Oslo University Hospital
Collaborating Sponsors:
St. Olavs Hospital
The Research Council of Norway
Conditions:
DCIS Grade 3
Stage I Breast Cancer
Eligibility:
FEMALE
18-75 years
Phase:
NA
Brief Summary
The purpose of this study, the EBBA-II trial, is to determine whether a 12 month exercise program comprised of strength and endurance training among newly diagnosed breast cancer patients undergoing a...
Detailed Description
The EBBA (Energy Balance and Breast cancer Aspects)-II study is a randomized clinical 12 month physical activity intervention trial, including female breast cancer patients diagnosed with histological...
Eligibility Criteria
Inclusion
- Age 18-75 years
- Newly diagnosed DCIS grade 3 or invasive breast cancer stage I, II, histologically verified.
- All ethnic groups, but participants have to speak and write the Norwegian language.
- Ability to join and maintain an intervention for 12 months
Exclusion
- Verified heart disease
- Dysregulated diabetes mellitus or thyroid disorders
- Muscular and skeletal or other disorders excluding regular physical activity performance
- Body Mass Index \>40 kg/m2
- Previous surgical treatment for obesity
- Travel distance \>1.5 hour from home to study site
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2027
Estimated Enrollment :
545 Patients enrolled
Trial Details
Trial ID
NCT02240836
Start Date
September 1 2014
End Date
October 31 2027
Last Update
April 8 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Oslo University Hospital
Oslo, Norway
2
St. Olavs Hospital
Trondheim, Norway, 7000